Upgrade to SI Premium - Free Trial

Cognex Reports Less-Than-Fabulous Results for the Second Quarter of 2020

July 29, 2020 4:06 PM

NATICK, Mass.--(BUSINESS WIRE)-- Cognex Corporation (NASDAQ: CGNX) today reported financial results for the second quarter of 2020. Table 1 below shows selected financial data for Q2-20 compared with Q2-19 and Q1-20, and for the six months ended June 28, 2020 compared with the same period in 2019. Notably, Cognex recorded significant restructuring and other charges, totaling over $42 million, in Q2-20 that reduced earnings for the quarter by $0.20 per diluted share.

Table 1

(Dollars in thousands, except per share amounts)

Revenue

Net
Income/(Loss)

Net
Income/(Loss)
per Diluted
Share

Non-GAAP
Net Income
per Diluted
Share*

Quarterly Comparisons

Current quarter: Q2-20

$169,097

$(1,142)

$(0.01)

$0.18

Prior year’s quarter: Q2-19

$199,047

$48,749

$0.28

$0.28

Change: Q2-19 to Q2-20

(15)%

(102)%

(104)%

(36)%

Prior quarter: Q1-20

$167,235

$20,477

$0.12

$0.11

Change: Q1-20 to Q2-20

1%

(106)%

(108)%

64%

Year-to-Date Comparisons

Six months ended June 28, 2020

$336,332

$19,335

$0.11

$0.29

Six months ended June 30, 2019

$372,531

$81,853

$0.47

$0.45

Change from first six months of 2019 to first six months of 2020

(10)%

(76)%

(77)%

(36)%

*Non-GAAP net income per diluted share excludes restructuring and other charges that occurred only in Q2-20 and tax adjustments for all periods presented. A reconciliation from GAAP to Non-GAAP is shown in Exhibit 2 of this news release.

“As we expected, the second quarter was very difficult for Cognex as it was for many companies around the world,” said Dr. Robert J. Shillman, Founder and Chairman of Cognex. “Because of the poor business conditions due to government-imposed shutdowns attributed to COVID-19, we found it necessary to implement significant changes to our company that, we believe, will put us in a stronger position going forward.”

“Few companies, including Cognex, are happy with their operating results this quarter,” said Robert J. Willett, Chief Executive Officer of Cognex. “However, we accomplished a lot by moving quickly to support customers and win business remotely, continue our product development schedules, and reconfigure our company for future growth. Machine vision remains a great business with substantial long-term growth potential, and we intend to continue leading the way as companies around the world resume their manufacturing efforts.”

“Order activity was strong during Q2 in both the consumer electronics and e-commerce markets, and we believe that bodes well for revenue in Q3. As a result, we expect to report growth next quarter on both a year-on-year and sequential basis despite tepid demand in the broader factory automation market,” concluded Mr. Willett.

Pre-tax Restructuring and Other Charges in Q2 2020

On May 26, 2020, the Board of Directors approved actions intended to reduce expenses and increase operating efficiencies. This included an 8% reduction in Cognex’s worldwide headcount, closure of leased office space, and reduced compensation for Chairman Dr. Shillman, CEO Mr. Willett, and the company’s other board members through the end of 2020. As a result of the restructuring, Cognex recorded a pre-tax charge of $14.8 million in Q2-20. Cognex also recorded pre-tax charges of $19.6 million for the impairment of intangible assets and $7.7 million for the write-down of excess and obsolete inventory in Q2-20 due to difficult business conditions the company is currently experiencing in many of its markets.

Details of the Quarter

Statement of Operations Highlights – Second Quarter of 2020

Balance Sheet Highlights – June 28, 2020

Financial Outlook – Q3 2020

Non-GAAP Financial Measures

About Cognex Corporation

Cognex Corporation designs, develops, manufactures, and markets a wide range of image-based products, all of which use artificial intelligence (AI) techniques that give them the human-like ability to make decisions on what they see. Cognex products include machine vision systems, machine vision sensors and barcode readers that are used in factories and distribution centers around the world where they eliminate production and shipping errors.

Cognex is the world's leader in the machine vision industry, having shipped more than 2.3 million image-based products, representing over $7 billion in cumulative revenue, since the company's founding in 1981. Headquartered in Natick, Massachusetts, USA, Cognex has offices and distributors located throughout the Americas, Europe and Asia. For details visit Cognex online at www.cognex.com.

Certain statements made in this news release, which do not relate solely to historical matters, are forward-looking statements. These statements can be identified by use of the words “expects,” “anticipates,” “estimates,” “believes,” “projects,” “intends,” “plans,” “will,” “may,” “shall,” “could,” “should,” and similar words and other statements of a similar sense. These forward-looking statements, which include statements regarding business and market trends, future financial performance, the expected impact of the COVID-19 pandemic on Cognex’s business and results of operations, customer order rates and timing of related revenue, future product mix, restructuring and other cost savings initiatives, research and development activities, investments, liquidity, strategic plans, and estimated tax benefits and expenses and other tax matters, involve known and unknown risks and uncertainties that could cause actual results to differ materially from those projected. Such risks and uncertainties include (1) the impact, duration and severity of the COVID-19 pandemic; (2) current and future conditions in the global economy, including the impact of the COVID-19 pandemic and the imposition of tariffs or export controls; (3) the loss of, or curtailment of purchases by, a large customer; (4) the reliance on revenue from the consumer electronics or automotive industries; (5) the inability to penetrate the logistics industry and other new markets; (6) the inability to achieve significant international revenue; (7) fluctuations in foreign currency exchange rates and the use of derivative instruments; (8) information security breaches or business system disruptions; (9) the inability to attract and retain skilled employees; (10) the failure to effectively manage our growth; (11) the reliance upon key suppliers to manufacture and deliver critical components for our products; (12) the failure to effectively manage product transitions or accurately forecast customer demand; (13) the inability to design and manufacture high-quality products; (14) the technological obsolescence of current products and the inability to develop new products; (15) the failure to properly manage the distribution of products and services; (16) the inability to protect our proprietary technology and intellectual property; (17) our involvement in time-consuming and costly litigation; (18) the impact of competitive pressures; (19) the challenges in integrating and achieving expected results from acquired businesses, including the recent acquisition of Sualab; (20) potential impairment charges with respect to our investments or for acquired intangible assets or goodwill; (21) exposure to additional tax liabilities; and (22) potential disruptions to our business due to restructuring activities and the failure of such activities to generate the anticipated cost savings; and the other risks detailed in Cognex reports filed with the SEC, including its Form 10-K for the fiscal year ended December 31, 2019 and Form 10-Q for the fiscal quarter ended June 28, 2020. You should not place undue reliance upon any such forward-looking statements, which speak only as of the date made. Cognex disclaims any obligation to update forward-looking statements after the date of such statements.

Exhibit 1

COGNEX CORPORATION

Statements of Operations

(Unaudited)

Dollars in thousands, except per share amounts

Three-months Ended

Six-months Ended

June 28, 2020

March 29, 2020

June 30, 2019

June 28, 2020

June 30, 2019

Revenue

$

169,097

$

167,235

$

199,047

$

336,332

$

372,531

Cost of revenue (1)

50,320

41,200

50,967

91,520

97,251

Gross margin

118,777

126,035

148,080

244,812

275,280

Percentage of revenue

70

%

75

%

74

%

73

%

74

%

Research, development, and engineering expenses (1)

30,397

35,946

28,079

66,343

58,321

Percentage of revenue

18

%

21

%

14

%

20

%

16

%

Selling, general, and administrative expenses (1)

60,153

69,138

68,245

129,291

135,056

Percentage of revenue

36

%

41

%

34

%

38

%

36

%

Restructuring charges

14,798

14,798

Intangible asset impairment charges

19,571

19,571

Operating income (loss)

(6,142

)

20,951

51,756

14,809

81,903

Percentage of revenue

(4

)%

13

%

26

%

4

%

22

%

Foreign currency gain (loss)

336

(3,003

)

140

(2,667

)

(108

)

Investment and other income

3,494

5,046

5,079

8,540

10,911

Income (loss) before income tax expense (benefit)

(2,312

)

22,994

56,975

20,682

92,706

Income tax expense (benefit)

(1,170

)

2,517

8,226

1,347

10,853

Net income (loss)

$

(1,142

)

$

20,477

$

48,749

$

19,335

$

81,853

Percentage of revenue

(1

)%

12

%

24

%

6

%

22

%

Net income (loss) per weighted-average common and common-equivalent share:

Basic

$

(0.01

)

$

0.12

$

0.28

$

0.11

$

0.48

Diluted

$

(0.01

)

$

0.12

$

0.28

$

0.11

$

0.47

Weighted-average common and common-equivalent shares outstanding:

Basic

172,283

172,408

171,318

172,345

171,209

Diluted

172,283

175,602

175,448

175,499

175,528

Cash dividends per common share

$

0.055

$

0.055

$

0.050

$

0.110

$

0.100

Cash and investments per common share

$

5.18

$

4.92

$

5.05

$

5.18

$

5.05

Book value per common share

$

7.95

$

7.73

$

6.98

$

7.95

$

6.98

(1) Amounts include stock-based compensation expense, as follows:

Cost of revenue

$

363

$

354

$

329

$

717

$

780

Research, development, and engineering

2,401

5,366

3,550

7,767

8,017

Selling, general, and administrative

5,254

9,070

7,088

14,324

14,451

Total stock-based compensation expense

$

8,018

$

14,790

$

10,967

$

22,808

$

23,248

Exhibit 2

COGNEX CORPORATION

Reconciliation of Selected Items from GAAP to Non-GAAP

(Unaudited)

Dollars in thousands, except per share amounts

Three-months Ended

Six-months Ended

June 28, 2020

March 29, 2020

June 30, 2019

June 28, 2020

June 30, 2019

Adjustment for stock expense and tax benefit for stock exercises

Operating income (loss) (GAAP)

$

(6,142

)

$

20,951

$

51,756

$

14,809

$

81,903

Stock-based compensation expense

8,018

14,790

10,967

22,808

23,248

Operating income (Non-GAAP)

$

1,876

$

35,741

$

62,723

$

37,617

$

105,151

Percentage of revenue (Non-GAAP)

1

%

21

%

32

%

11

%

28

%

Net income (loss) (GAAP)

$

(1,142

)

$

20,477

$

48,749

$

19,335

$

81,853

Stock-based compensation expense

8,018

14,790

10,967

22,808

23,248

Tax effect on stock-based compensation expense

(1,277

)

(2,564

)

(1,813

)

(3,841

)

(4,035

)

Discrete tax benefit related to stock-based compensation

(4,413

)

(1,680

)

(1,248

)

(6,093

)

(3,978

)

Net income (Non-GAAP)

$

1,186

$

31,023

$

56,655

$

32,209

$

97,088

Percentage of revenue (Non-GAAP)

1

%

19

%

28

%

10

%

26

%

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP)

$

(0.01

)

$

0.12

$

0.28

$

0.11

$

0.47

Per share impact of non-GAAP adjustments identified above

0.02

0.06

0.04

0.07

0.08

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.01

$

0.18

$

0.32

$

0.18

$

0.55

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

175,403

175,602

175,448

175,499

175,528

Exclusion of tax adjustments

Income (loss) before income tax expense (benefit) (GAAP)

$

(2,312

)

$

22,994

$

56,975

$

20,682

$

92,706

Income tax expense (benefit) (GAAP)

$

(1,170

)

$

2,517

$

8,226

$

1,347

$

10,853

Effective tax rate (GAAP)

(51

)%

11

%

14

%

7

%

12

%

Tax adjustments:

Discrete tax benefit related to stock-based compensation

4,413

1,680

1,248

6,093

3,978

Discrete tax benefit (expense) related to tax return filings and other

(3,267

)

(242

)

(3,509

)

3

Tax rate adjustment

(415

)

Income tax expense (benefit) (Non-GAAP)

$

(439

)

$

3,955

$

9,474

$

3,931

$

14,834

Effective tax rate (Non-GAAP)

(19

)%

17

%

17

%

19

%

16

%

Net income (loss) (Non-GAAP)

$

(1,873

)

$

19,039

$

47,501

$

16,751

$

77,872

Percentage of revenue (Non-GAAP)

(1

)%

11

%

24

%

5

%

21

%

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP)

$

(0.01

)

$

0.12

$

0.28

$

0.11

$

0.47

Per share impact of non-GAAP adjustments identified above

(0.01

)

(0.01

)

(0.01

)

(0.03

)

Net income (loss) per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

(0.01

)

$

0.11

$

0.27

$

0.10

$

0.44

Diluted weighted-average common and common-equivalent shares outstanding (GAAP)

172,283

175,602

175,448

175,499

175,528

Exhibit 2

Three-months Ended

Six-months Ended

June 28, 2020

March 29, 2020

June 30, 2019

June 28, 2020

June 30, 2019

Exclusion of restructuring and other charges

Gross margin (GAAP)

$

118,777

$

126,035

$

148,080

$

244,812

$

275,280

Excess and obsolete inventory charges

7,718

1,065

933

8,783

1,713

Gross margin (Non-GAAP)

$

126,495

$

127,100

$

149,013

$

253,595

$

276,993

Percentage of revenue (Non-GAAP)

75

%

76

%

75

%

75

%

74

%

Operating income (loss) (GAAP)

$

(6,142

)

$

20,951

$

51,756

$

14,809

$

81,903

Excess and obsolete inventory charges

7,718

1,065

933

8,783

1,713

Restructuring charges

14,798

14,798

Intangible asset impairment charges

19,571

19,571

Operating income (Non-GAAP)

$

35,945

$

22,016

$

52,689

$

57,961

$

83,616

Percentage of revenue (Non-GAAP)

21

%

13

%

26

%

17

%

22

%

Net income (loss) (GAAP)

$

(1,142

)

$

20,477

$

48,749

$

19,335

$

81,853

Excess and obsolete inventory charges

7,718

1,065

933

8,783

1,713

Restructuring charges

14,798

14,798

Intangible asset impairment charges

19,571

19,571

Tax effect on restructuring and other charges

(7,997

)

(181

)

(159

)

(8,199

)

(274

)

Net income (Non-GAAP)

$

32,948

$

21,361

$

49,523

$

54,288

$

83,292

Percentage of revenue (Non-GAAP)

19

%

13

%

25

%

16

%

22

%

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP)

$

(0.01

)

$

0.12

$

0.28

$

0.11

$

0.47

Per share impact of non-GAAP adjustments identified above

0.20

0.20

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.19

$

0.12

$

0.28

$

0.31

$

0.47

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

175,403

175,602

175,448

175,499

175,528

Three-months Ended

Six-months Ended

June 28, 2020

March 29, 2020

June 30, 2019

June 28, 2020

June 30, 2019

Exclusion of restructuring and other charges and tax adjustments

Net income (loss) (GAAP)

$

(1,142

)

$

20,477

$

48,749

$

19,335

$

81,853

Excess and obsolete inventory charges

7,718

1,065

933

8,783

1,713

Restructuring charges

14,798

14,798

Intangible asset impairment charges

19,571

19,571

Tax effect on restructuring and other charges

(7,997

)

(181

)

(159

)

(8,199

)

(274

)

Tax adjustments

(731

)

(1,438

)

(1,248

)

(2,584

)

(3,981

)

Net income (Non-GAAP)

$

32,217

$

19,923

$

48,275

$

51,704

$

79,311

Percentage of revenue (Non-GAAP)

19

%

12

%

24

%

15

%

21

%

Net income (loss) per diluted weighted-average common and common-equivalent share (GAAP)

$

(0.01

)

$

0.12

$

0.28

$

0.11

$

0.47

Per share impact of non-GAAP adjustments identified above

0.19

(0.01

)

0.18

(0.02

)

Net income per diluted weighted-average common and common-equivalent share (Non-GAAP)

$

0.18

$

0.11

$

0.28

$

0.29

$

0.45

Diluted weighted-average common and common-equivalent shares outstanding (Non-GAAP)

175,403

175,602

175,448

175,499

175,528

Exhibit 3

COGNEX CORPORATION

Balance Sheets

(Unaudited)

Dollars in thousands

June 28, 2020

December 31, 2019

Assets

Cash and investments

$

896,192

$

845,353

Accounts receivable

111,671

103,447

Inventories

52,953

60,261

Property, plant, and equipment

83,936

89,443

Operating lease assets

25,819

17,522

Goodwill and intangible assets

259,773

282,935

Deferred tax assets

443,732

449,519

Other assets

60,788

37,455

Total assets

$

1,934,864

$

1,885,935

Liabilities and Shareholders' Equity

Accounts payable and accrued expenses

$

84,263

$

70,065

Deferred revenue and customer deposits

46,738

14,432

Operating lease liabilities

28,836

17,973

Income taxes

67,169

93,009

Deferred tax liabilities

326,295

332,344

Other liabilities

5,085

2,402

Shareholders' equity

1,376,478

1,355,710

Total liabilities and shareholders' equity

$

1,934,864

$

1,885,935

Susan Conway

Investor Relations

+1 508-650-3353

[email protected]

Source: Cognex Corporation

Categories

Business Wire Press Releases

Next Articles